검색
Bausch Health Companies Inc
BHC관심 목록에 추가
5.460USD
+0.170+3.21%
종가 05/14, 16:00（ET）시세는 15분 지연됩니다
2.04B시가총액
손실P/E TTM
자세한 내용은 Bausch Health Companies Inc 회사
Bausch Health Companies Inc. is a global, diversified pharmaceutical company. The Salix segment includes sales in the U.S. of GI products. The International segment includes sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the U.S. and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products and OTC products. The Solta Medical segment includes global sales of Solta Medical aesthetic medical devices. The Diversified segment includes sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, dermatology products, generic pharmaceutical products and dentistry products. The Bausch + Lomb segment includes global sales of Bausch + Lomb Vision Care, Surgical and Pharmaceuticals products. Its drug candidate, Larsucosterol binds to and inhibits the activity of DNA methyltransferases, epigenetic enzymes that are elevated and associated with hypermethylation found in AH patients.
Bausch Health Companies Inc 정보
종목 코드 BHC
회사 이름Bausch Health Companies Inc
상장일Sep 20, 1994
CEOAppio (Thomas J)
직원 수20700
유형Ordinary Share
회계 연도 종료Sep 20
주소2150 St. Elzear Blvd. West
도시LAVAL
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가Canada
우편 번호H7L 4A8
전화18003611448
웹사이트https://www.bauschhealth.com/
종목 코드 BHC
상장일Sep 20, 1994
CEOAppio (Thomas J)
Bausch Health Companies Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Thomas J. Appio
Mr. Thomas J. Appio
Chief Executive Officer, Director
Chief Executive Officer, Director
903.22K
-173.57%
Mr. Jean-Jacques (JJ) Charhon
Mr. Jean-Jacques (JJ) Charhon
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
440.81K
+54.80%
Ms. Aimee J. Lenar
Ms. Aimee J. Lenar
Executive Vice President, US Pharma
Executive Vice President, US Pharma
164.94K
+84.61%
Dr. Amy B. Wechsler, M.D.
Dr. Amy B. Wechsler, M.D.
Independent Director
Independent Director
107.87K
-0.72%
Mr. Robert N. Power
Mr. Robert N. Power
Independent Director
Independent Director
6.60K
--
Ms. Sandra Leung
Ms. Sandra Leung
Director
Director
5.95K
-38.90%
Ms. Sarah B. Kavanagh
Ms. Sarah B. Kavanagh
Independent Director
Independent Director
--
--
Mr. John A. Paulson ,
Mr. John A. Paulson ,
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
--
Dr. Richard C. Mulligan, Ph.D.
Dr. Richard C. Mulligan, Ph.D.
Independent Director
Independent Director
--
--
Ms. Seana Carson
Ms. Seana Carson
Executive Vice President, General Counsel
Executive Vice President, General Counsel
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Thomas J. Appio
Mr. Thomas J. Appio
Chief Executive Officer, Director
Chief Executive Officer, Director
903.22K
-173.57%
Mr. Jean-Jacques (JJ) Charhon
Mr. Jean-Jacques (JJ) Charhon
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
440.81K
+54.80%
Ms. Aimee J. Lenar
Ms. Aimee J. Lenar
Executive Vice President, US Pharma
Executive Vice President, US Pharma
164.94K
+84.61%
Dr. Amy B. Wechsler, M.D.
Dr. Amy B. Wechsler, M.D.
Independent Director
Independent Director
107.87K
-0.72%
Mr. Robert N. Power
Mr. Robert N. Power
Independent Director
Independent Director
6.60K
--
Ms. Sandra Leung
Ms. Sandra Leung
Director
Director
5.95K
-38.90%
수익 분석
통화: USD마지막 업데이트: Mon, Apr 6
통화: USD마지막 업데이트: Mon, Apr 6
FY2025
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
Pharmaceutical Products
4.75B
46.24%
Device Products
2.44B
23.76%
OTC
2.01B
19.56%
Branded and Other Generic Products
962.00M
9.37%
Other Product Lines
110.00M
1.07%
지역별USD
이름
수익
비율
United States and Puerto Rico
6.14B
59.79%
Other Foreign Countries
1.15B
11.23%
China (Country)
493.00M
4.80%
Canada
417.00M
4.06%
Poland
382.00M
3.72%
기타
1.68B
16.39%
사업별
지역별
사업별USD
이름
수익
비율
Pharmaceutical Products
4.75B
46.24%
Device Products
2.44B
23.76%
OTC
2.01B
19.56%
Branded and Other Generic Products
962.00M
9.37%
Other Product Lines
110.00M
1.07%
주식 보유 통계
마지막 업데이트: Sun, May 10
마지막 업데이트: Sun, May 10
주주
주주 유형
주주
주주
비율
Paulson (John A.)
19.62%
Paulson & Co. Inc.
19.61%
Meruelo (Alex)
9.84%
GoldenTree Asset Management, LP
9.28%
Nomura Securities Co., Ltd.
2.33%
기타
39.31%
주주
주주
비율
Paulson (John A.)
19.62%
Paulson & Co. Inc.
19.61%
Meruelo (Alex)
9.84%
GoldenTree Asset Management, LP
9.28%
Nomura Securities Co., Ltd.
2.33%
기타
39.31%
주주 유형
주주
비율
Individual Investor
30.54%
Family Office
19.64%
Investment Advisor/Hedge Fund
16.36%
Investment Advisor
9.28%
Hedge Fund
6.87%
Research Firm
4.78%
Bank and Trust
3.82%
Pension Fund
2.84%
Private Equity
1.40%
기타
4.48%
기관 주식 보유
마지막 업데이트: Wed, Apr 1
마지막 업데이트: Wed, Apr 1
보고 기간
기관 수
보유 주식
비율
변동
2026Q1
510
173.34M
46.41%
-64.50M
2025Q4
488
175.10M
70.29%
+43.88K
2025Q3
506
175.09M
71.73%
-42.59M
2025Q2
513
217.71M
72.26%
-4.52M
2025Q1
526
222.33M
72.55%
-45.74M
2024Q4
547
234.63M
78.06%
-1.57M
2024Q3
606
235.66M
83.60%
-25.41M
2024Q2
682
261.12M
90.70%
-4.43M
2024Q1
745
265.27M
94.42%
-80.93M
2023Q4
778
267.72M
94.93%
+4.99M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Paulson & Co. Inc.
73.26M
19.77%
--
--
Dec 31, 2025
Meruelo (Alex)
36.76M
9.92%
+148.73K
+0.41%
Mar 31, 2025
GoldenTree Asset Management, LP
34.67M
9.35%
-167.70K
-0.48%
Dec 31, 2025
Nomura Securities Co., Ltd.
8.70M
2.35%
-7.01M
-44.62%
Dec 31, 2025
Healthcare Of Ontario Pension Plan
8.45M
2.28%
-4.55M
-34.98%
Dec 31, 2025
MFN Partners Management LP
6.00M
1.62%
--
--
Dec 31, 2025
National Bank of Canada
5.32M
1.43%
-2.41M
-31.17%
Dec 31, 2025
Kohlberg Kravis Roberts & Co. L.P.
5.24M
1.41%
--
--
Dec 31, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
VanEck Pharmaceutical ETF
0.3%
Gotham 1000 Value ETF
0.18%
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index ETF
0.12%
Schwab International Small-Cap Equity ETF
0.09%
iShares Intl Small Cap Equity Factor ETF
0.08%
DFA Dimensional International Small Cap ETF
0.07%
Schwab Fundamental International Equity ETF
0.04%
Invesco RAFI Developed Mkts ex-US ETF
0.03%
DFA Dimensional Intl Sustainability Core 1 ETF
0.01%
iShares Core MSCI International Developed Mkt ETF
0.01%
더 보기
VanEck Pharmaceutical ETF
비율0.3%
Gotham 1000 Value ETF
비율0.18%
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index ETF
비율0.12%
Schwab International Small-Cap Equity ETF
비율0.09%
iShares Intl Small Cap Equity Factor ETF
비율0.08%
DFA Dimensional International Small Cap ETF
비율0.07%
Schwab Fundamental International Equity ETF
비율0.04%
Invesco RAFI Developed Mkts ex-US ETF
비율0.03%
DFA Dimensional Intl Sustainability Core 1 ETF
비율0.01%
iShares Core MSCI International Developed Mkt ETF
비율0.01%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
